Connect Biopharma Holdings Limited
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.About CNTB
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.
CEOBarry D. Quart
CEOBarry D. Quart
Employees62
Employees62
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2015
Founded2015
Employees62
Employees62
CNTB Key Statistics
Market cap89.71M
Market cap89.71M
Price-Earnings ratio-5.69
Price-Earnings ratio-5.69
Dividend yield—
Dividend yield—
Average volume118.63K
Average volume118.63K
High today—
High today—
Low today—
Low today—
Open price$1.64
Open price$1.64
Volume0.00
Volume0.00
52 Week high$2.86
52 Week high$2.86
52 Week low$0.51
52 Week low$0.51
CNTB News
TipRanks 2d
Connect Biopharma Executives Increase Share HoldingsElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own CNTB. This list is generated using Robinhood data, and it’s not a recommendation.